Figure 9 — Neuroprotective effects of protocatechuic aldehyde through PLK2/p-GSK3β/Nrf2 signaling pathway in both in vivo and in vitro models of Parkinson's disease

Research Paper|Volume 11, Issue 21|pp. 9424–9441

Neuroprotective effects of protocatechuic aldehyde through PLK2/p-GSK3β/Nrf2 signaling pathway in both in vivo and in vitro models of Parkinson's disease

Back to articleFigure 9(9 of 12)

100%

Figure 9.BI2536 (BI) reversed the neuroprotection effect of PCA. (A) Rotarod test in control, MPTP, PCA+MPTP and PCA+MPTP+BI group. (B) Pole test in each group. (C) TH levels from SN tissues were measured by ELISA. Data were expressed as mean ± S.D., n=6; ^*P< 0.05, ^**P< 0.01 vs. control group; ^#P< 0.05 vs. MPTP group, ^&P< 0.05 vs. PCA+MPTP group.